Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Multiple Sclerosis and Related Disorders
|
March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 5, 2024
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study
Liana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, et al.
World Journal of Gastroenterology
|
April 26, 2014
Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial
Shira Zelber-Sagi, Assaf Buch, Hanny Yeshua, et al.
Journal of Neuroimmunology
|
October 16, 2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Communications Biology
|
January 17, 2020
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolution
Noam Mamet, Yaniv Amir, Erez Lavi, et al.
Oncotarget
|
May 27, 2015
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
Talia Golan, Elina Zorde Khvalevsky, Ayala Hubert, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Multiple Sclerosis and Related Disorders
|
March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 5, 2024
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study
Liana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, et al.
World Journal of Gastroenterology
|
April 26, 2014
Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial
Shira Zelber-Sagi, Assaf Buch, Hanny Yeshua, et al.
Journal of Neuroimmunology
|
October 16, 2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Communications Biology
|
January 17, 2020
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolution
Noam Mamet, Yaniv Amir, Erez Lavi, et al.
Oncotarget
|
May 27, 2015
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
Talia Golan, Elina Zorde Khvalevsky, Ayala Hubert, et al.
Page
of 4